Stay updated on APL-501 with APL-101 in HCC and RCC Clinical Trial
Sign up to get notified when there's something new on the APL-501 with APL-101 in HCC and RCC Clinical Trial page.

Latest updates to the APL-501 with APL-101 in HCC and RCC Clinical Trial page
- Check7 days agoChange DetectedThe page's Revision label was updated from v3.6.5 to v3.6.6, indicating a new software build or patch. This appears to be a backend update rather than a modification to study text or data.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page revision tag was updated to v3.6.5, replacing the previous v3.6.4 in the page history.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision tag on the page updated to v3.6.4 from v3.6.3, signaling a minor update to the site's versioning rather than a substantive change to study information.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page revision label updated from v3.6.2 to v3.6.3, indicating a new revision of the page. This reflects an administrative update to the page's metadata rather than changes to the study data.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision metadata on the study page updated from v3.6.0 to v3.6.2, indicating a newer version of the study record. The change does not alter the study content, eligibility criteria, or participant-facing information.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page now indicates recruitment is closed by adding 'No longer looking for participants' and introduces new help sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The header for the treatment section changes from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision tag updates from v3.5.5 to v3.6.0.SummaryDifference0.5%

Stay in the know with updates to APL-501 with APL-101 in HCC and RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-501 with APL-101 in HCC and RCC Clinical Trial page.